Anthem Biosciences Ltd Half Yearly Results

Gross Sales

1,090.24

981

863.55

Excise Duty

0

0

0

Net Sales

1,090.24

981

863.55

Other Operating Income

0

0

0

Other Income

71.04

38.43

47.3

Total Income

1,161.28

1,019.44

910.85

Total Expenditure

680.84

626.3

547.42

PBIDT

480.44

393.13

363.43

Interest

4.64

3.07

7.26

PBDT

475.8

390.06

356.18

Depreciation

59.95

50.7

38.67

Minority Interest Before NP

0

0

0

Tax

113.82

99.3

82.72

Deferred Tax

-7.19

33.1

-9.52

Reported Profit After Tax

309.22

206.95

244.31

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

309.22

206.95

244.31

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

309.22

206.95

244.31

EPS (Unit Curr.)

5.52

3.7

4.37

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

112.32

111.82

112.32

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

44.06

40.07

42.08

PBDTM(%)

-

-

-

PATM(%)

28.36

21.09

28.29